BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16322093)

  • 1. Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals.
    Sterpetti P; Marucci L; Candelaresi C; Toksoz D; Alpini G; Ugili L; Baroni GS; Macarri G; Benedetti A
    Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G624-32. PubMed ID: 16322093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Lbc RhoGEF in Galpha12/13-induced signals to Rho GTPase.
    Dutt P; Nguyen N; Toksoz D
    Cell Signal; 2004 Feb; 16(2):201-9. PubMed ID: 14636890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
    Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
    J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction.
    Manov I; Pollak Y; Broneshter R; Iancu TC
    FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma.
    Breunig C; Mueller BJ; Umansky L; Wahl K; Hoffmann K; Lehner F; Manns MP; Bantel H; Falk CS
    Clin Cancer Res; 2014 May; 20(9):2410-23. PubMed ID: 24573550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
    Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
    FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation.
    Park B; Nguyen NT; Dutt P; Merdek KD; Bashar M; Sterpetti P; Tosolini A; Testa JR; Toksoz D
    J Biol Chem; 2002 Nov; 277(47):45361-70. PubMed ID: 12270917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex.
    Diviani D; Abuin L; Cotecchia S; Pansier L
    EMBO J; 2004 Jul; 23(14):2811-20. PubMed ID: 15229649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.
    Yue L; Wang Y; Wang H; Gao H; Liang J; Sui A; Xiang J; Zhou F; Xu C; Zhao W; Liang W; Yao R
    Oncol Rep; 2012 Oct; 28(4):1453-60. PubMed ID: 22895605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin reverses tunicamycin-induced endoplasmic reticulum stress in human hepatocellular carcinoma cells and improves cytotoxic response to doxorubicin by increasing CHOP and decreasing survivin.
    Fan L; Sun G; Ma T; Zhong F; Lei Y; Li X; Wei W
    J Pineal Res; 2013 Sep; 55(2):184-94. PubMed ID: 23711089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C; Baron A; Blivet-Van Eggelpoël MJ; Fartoux L; Venot C; Bladt F; Housset C; Rosmorduc O
    Clin Cancer Res; 2009 Sep; 15(17):5445-56. PubMed ID: 19706799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor.
    Pi M; Spurney RF; Tu Q; Hinson T; Quarles LD
    Endocrinology; 2002 Oct; 143(10):3830-8. PubMed ID: 12239094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway.
    Liao J; Xu T; Zheng JX; Lin JM; Cai QY; Yu DB; Peng J
    Int J Mol Med; 2013 Jul; 32(1):79-84. PubMed ID: 23613111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.
    Gopalan B; Narayanan K; Ke Z; Lu T; Zhang Y; Zhuo L
    Biomaterials; 2014 Aug; 35(26):7479-87. PubMed ID: 24912819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho GDP dissociation inhibitor beta promotes cell proliferation and invasion by modulating the AKT pathway in hepatocellular carcinoma.
    Fang Y; Yi J; Lizhi L; Qiucheng C
    DNA Cell Biol; 2014 Nov; 33(11):781-6. PubMed ID: 25180836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
    Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
    Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Chak EC; Lai PB
    Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Cheng P; Dai W; Wang F; Lu J; Shen M; Chen K; Li J; Zhang Y; Wang C; Yang J; Zhu R; Zhang H; Zheng Y; Guo CY; Xu L
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1162-8. PubMed ID: 24361892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.